Literature DB >> 27481151

Frequency of psycho-oncologic and social service counseling in cancer centers relative to center site and hospital characteristics: Findings from 879 center sites in Germany, Austria, Switzerland, and Italy.

Christoph Kowalski1, Julia Ferencz2, Susanne Singer3, Ilse Weis4, Simone Wesselmann1.   

Abstract

BACKGROUND: There is extensive evidence that patients with cancer and cancer survivors have a strong need for expert support in relation to the psychological and social consequences of the disease. The requirements set out in the German Cancer Society's cancer center certification system include the routine provision of psycho-oncologic care (POC) and social service counseling for every patient. The current study investigated which organizational and structural characteristics in hospitals account for variations in psychosocial care provision in these centers.
METHODS: Data routinely collected during the certification process regarding the percentages of psychosocial care provision and characteristics of center sites and hospitals were matched with data with regard to size of the municipality, teaching hospital status, and institutional ownership. Linear multilevel regression analyses were performed to identify the characteristics of hospitals and center sites that were related to psychosocial care provision.
RESULTS: Substantial differences were found for different types of cancer (eg, a greater provision of psychosocial care in centers specializing in breast rather than prostate cancer). There was more POC provision in longer-certified centers and less in rural areas and university hospitals. Much of the variation between hospitals remains unexplained.
CONCLUSIONS: Although the implementation of mandatory psychosocial services generally provides patients with access to POC and social service counseling, the wide differences in the provision of counseling indicate that additional measures are needed to avoid inequalities resulting from the center at which a patient receives cancer treatment. Cancer 2016;122:3538-3545.
© 2016 American Cancer Society. © 2016 American Cancer Society.

Entities:  

Keywords:  cancer centers; certification; health care disparities; multidisciplinary treatment; psycho-oncology; social work

Year:  2016        PMID: 27481151     DOI: 10.1002/cncr.30202

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  9 in total

1.  The effects of multi-disciplinary psycho-social care on socio-economic problems in cancer patients: a cluster-randomized trial.

Authors:  Susanne Singer; Julia Roick; Jürgen Meixensberger; Franziska Schiefke; Susanne Briest; Andreas Dietz; Kirsten Papsdorf; Joachim Mössner; Thomas Berg; Jens-Uwe Stolzenburg; Dietger Niederwieser; Annette Keller; Anette Kersting; Helge Danker
Journal:  Support Care Cancer       Date:  2017-12-21       Impact factor: 3.603

2.  Awareness, offer, and use of psychosocial services by breast cancer survivors in Germany: a prospective multi-centre study.

Authors:  Susanne Singer; Wolfgang Janni; Thorsten Kühn; Felix Flock; Ricardo Felberbaum; Lukas Schwentner; Elena Leinert; Achim Wöckel; Tanja Schlaiß
Journal:  Arch Gynecol Obstet       Date:  2022-07-15       Impact factor: 2.493

3.  Experience of office-based haematologists and oncologists with outpatient psycho-social support services for cancer patients with and without migration background in Germany.

Authors:  Nicola Riccetti; Isabelle Hempler; Kerstin Hermes-Moll; Vitali Heidt; Thomas Walawgo; Susanne Singer
Journal:  J Cancer Res Clin Oncol       Date:  2022-09-02       Impact factor: 4.322

4.  Awareness and use of psychosocial care among cancer patients and their relatives-a comparison of people with and without a migration background in Germany.

Authors:  Susanne Singer; Nicola Riccetti; Isabelle Hempler; Marius Fried; Jorge Riera Knorrenschild; Louma Kalie; Martin Merbach; Marcel Reiser; Franz Mosthaf; Vitali Heidt; Kerstin Hermes-Moll
Journal:  J Cancer Res Clin Oncol       Date:  2022-06-11       Impact factor: 4.322

5.  The use of psychological supportive care services and psychotropic drugs in patients with early-stage breast cancer: a comparison between two institutions on two continents.

Authors:  Orit Kaidar-Person; Icro Meattini; Allison M Deal; Giulio Francolini; Giulio Carta; Lauren Terzo; Jayne Camporeale; Hyman Muss; Lawrence B Marks; Lorenzo Livi; Deborah K Mayer; Timothy M Zagar
Journal:  Med Oncol       Date:  2017-07-19       Impact factor: 3.064

6.  [Psycho-oncology in dermatological practice : Evaluation of need and care structures].

Authors:  Frank Meiss; Katrin Reuter; Katharina Müller; Matthias Augustin; Ines Schäfer; Dorothée Nashan
Journal:  Hautarzt       Date:  2019-04       Impact factor: 0.751

7.  Organizing Psycho-Oncological Care for Cancer Patients: The Patient's Perspective.

Authors:  Anouk S Schuit; Karen Holtmaat; Valesca van Zwieten; Eline J Aukema; Lotte Gransier; Pim Cuijpers; Irma M Verdonck-de Leeuw
Journal:  Front Psychol       Date:  2021-04-22

8.  Predictors for the utilization of social service counseling by prostate cancer patients.

Authors:  Clara Breidenbach; Lena Ansmann; Nora Tabea Sibert; Simone Wesselmann; Sebastian Dieng; Ernst-Günther Carl; Günter Feick; Cindy Stoklossa; Anne Taubert; Amanda Pomery; Burkhard Beyer; Andreas Blana; Marko Brock; Florian Distler; Michael Enge; Amr A Gaber; Christian Gilfrich; Andreas Hinkel; Björn Kaftan; Thomas Knoll; Frank Kunath; Simba-Joshua Oostdam; Inga Peters; Bülent Polat; Valentin Schrodi; Friedemann Zengerling; Christoph Kowalski
Journal:  Support Care Cancer       Date:  2021-11-04       Impact factor: 3.603

9.  Use of psycho-oncological services by prostate cancer patients: A multilevel analysis.

Authors:  Clara Breidenbach; Rebecca Roth; Lena Ansmann; Simone Wesselmann; Sebastian Dieng; Ernst-Günther Carl; Günter Feick; Alisa Oesterle; Peter Bach; Burkhard Beyer; Rainer Borowitz; Jörg Erdmann; Frank Kunath; Simba-Joshua Oostdam; Igor Tsaur; Friedemann Zengerling; Christoph Kowalski
Journal:  Cancer Med       Date:  2020-03-31       Impact factor: 4.452

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.